Immunotherapy of cancer: recent progress and future challenges

Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
Immunotherapy of cancer: recent progress and future challenges ( Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015

Epigenome deregulation in cancer

Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France
Epigenome deregulation in cancer ( Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France )
6 Jan 2015

Aims and successes of the 2nd EurocanPlatform project translational research course

Christina von Gertten, Karolinska Institutet, Stockholm, Sweden
Aims and successes of the 2nd EurocanPlatform project translational research course ( Christina von Gertten, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015

The DNA damage response and cancer therapy

Dr Christopher Lord, The Institute of Cancer Research, London, UK
The DNA damage response and cancer therapy ( Dr Christopher Lord, The Institute of Cancer Research, London, UK )
6 Jan 2015

New approaches and new partnership models for biomarker based clinical research

Dr Denis Lacombe, EORTC, Brussels, Belgium
New approaches and new partnership models for biomarker based clinical research ( Dr Denis Lacombe, EORTC, Brussels, Belgium )
6 Jan 2015

Patient and political advocacy in women's cancers

Sarah Goltz - Founder of Sage Innovation
Patient and political advocacy in women's cancers ( Sarah Goltz - Founder of Sage Innovation )
18 Dec 2014

WHO guidelines on preventing and screening for cervical cancer

Dr Nathalie Broutet – World Health Organization, Geneva, Switzerland
WHO guidelines on preventing and screening for cervical cancer ( Dr Nathalie Broutet – World Health Organization, Geneva, Switzerland )
18 Dec 2014

Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014

Biomarker for PARP inhibitor responsiveness in ovarian cancer patients

Prof Elizabeth Swisher - University of Washington, Washington, USA
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients ( Prof Elizabeth Swisher - University of Washington, Washington, USA )
27 Nov 2014

Targeting PI3K in female cancers

Dr Lewis Cantley - Weill Cornell Medical College, New York, USA
Targeting PI3K in female cancers ( Dr Lewis Cantley - Weill Cornell Medical College, New York, USA )
10 Nov 2014

Research shows chemotherapy has no negative effects on babies in utero

Prof Frederic Amant - University Hospital Leuven, Leuven, Belgium
Research shows chemotherapy has no negative effects on babies in utero ( Prof Frederic Amant - University Hospital Leuven, Leuven, Belgium )
1 Oct 2014

Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer

Dr Lucas Minig - Valencia Institute of Oncology, Valencia, Spain
Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer ( Dr Lucas Minig - Valencia Institute of Oncology, Valencia, Spain )
1 Oct 2014